|
ES2200184T7
(es)
|
1996-07-24 |
2015-02-10 |
Warner-Lambert Company Llc |
Isobutilgaba y sus derivados para el tratamiento del dolor
|
|
ES2260850T3
(es)
|
1997-10-27 |
2006-11-01 |
Warner-Lambert Company Llc |
Aminoaciods ciclicos y sus derivados utiles como agentes farmaceuticos.
|
|
DE19751062A1
(de)
*
|
1997-11-18 |
1999-07-08 |
Univ Ludwigs Albert |
An 4-Stellung substituierte 2-Pyrrolidinon-Derivate zur Verringerung des extrazellulären Glutamat-Spiegels
|
|
US6984659B2
(en)
|
1997-11-18 |
2006-01-10 |
Klinikum Der Albert-Ludwigs Universitaet |
2-pyrrolidinone derivatives substituted at position 4 for reducing the extracellular glutamate level
|
|
JP2002508362A
(ja)
*
|
1997-12-16 |
2002-03-19 |
ワーナー−ランバート・カンパニー |
１−置換−１−アミノメチル−シクロアルカン誘導体（＝ガバペンチン類縁体）、その製造および神経学的疾患の治療におけるその使用
|
|
AU772156B2
(en)
*
|
1998-07-09 |
2004-04-08 |
Warner-Lambert Company |
Compositions comprising GABA analogs and caffeine
|
|
EP1031350A1
(en)
*
|
1999-02-23 |
2000-08-30 |
Warner-Lambert Company |
Use of a gabapentin-analog for the manufacture of a medicament for preventing and treating visceral pain
|
|
US6992109B1
(en)
*
|
1999-04-08 |
2006-01-31 |
Segal Catherine A |
Method for the treatment of incontinence
|
|
CN1626069A
(zh)
*
|
1999-12-08 |
2005-06-15 |
沃尼尔·朗伯公司 |
支链氨基酸依赖性氨基转移酶的抑制剂及其在治疗糖尿病性视网膜病中的应用
|
|
JP2003528148A
(ja)
*
|
2000-03-28 |
2003-09-24 |
デロレンゾ、ロバート・ジェイ |
損傷に際して神経細胞中に形成される新規カルシウム損傷電流の阻害は神経細胞死を抑制する
|
|
GB2362646A
(en)
*
|
2000-05-26 |
2001-11-28 |
Warner Lambert Co |
Cyclic amino acid derivatives useful as pharmaceutical agents
|
|
DE10048715A1
(de)
*
|
2000-09-30 |
2004-05-19 |
Grünenthal GmbH |
Verwendung von Aminosäure zur Behandlung von Schmerz
|
|
EP1361847A2
(en)
*
|
2000-10-06 |
2003-11-19 |
Xenoport, Inc. |
Bile-acid conjugates for providing sustained systemic concentrations of drugs
|
|
EP1343805A4
(en)
*
|
2000-10-06 |
2005-07-20 |
Xenoport Inc |
COMPOUNDS DERIVED FROM GALLENIC ACIDS FOR THE PROVISION OF CONTINUING SYSTEMIC CONCENTRATIONS OF MEDICINAL PRODUCTS AFTER ORAL ADMINISTRATION
|
|
US6683112B2
(en)
*
|
2000-10-24 |
2004-01-27 |
Andrx Corporation |
Gabapentin prodrugs and formulations
|
|
GB2368579A
(en)
*
|
2000-10-31 |
2002-05-08 |
Parke Davis & Co Ltd |
Azole pharmaceutical agents
|
|
EP1337506A4
(en)
|
2000-11-02 |
2005-05-04 |
Teva Pharma |
IMPROVED METHOD FOR MANUFACTURING GABAPENTINE INTERMEDIATES
|
|
JP2004524339A
(ja)
*
|
2001-03-16 |
2004-08-12 |
ソルケム イタリアーナ エス．ピー．エイ． |
環状アミノ酸の調製方法
|
|
US6818787B2
(en)
|
2001-06-11 |
2004-11-16 |
Xenoport, Inc. |
Prodrugs of GABA analogs, compositions and uses thereof
|
|
WO2002100344A2
(en)
*
|
2001-06-11 |
2002-12-19 |
Xenoport, Inc. |
Amino acid conjugates providing for sustained systemic concentrations of gaba analogues
|
|
US8048917B2
(en)
|
2005-04-06 |
2011-11-01 |
Xenoport, Inc. |
Prodrugs of GABA analogs, compositions and uses thereof
|
|
US7232924B2
(en)
*
|
2001-06-11 |
2007-06-19 |
Xenoport, Inc. |
Methods for synthesis of acyloxyalkyl derivatives of GABA analogs
|
|
EP1404324B2
(en)
|
2001-06-11 |
2011-04-06 |
XenoPort, Inc. |
Prodrugs of gaba analogs, compositions and uses thereof
|
|
US7186855B2
(en)
*
|
2001-06-11 |
2007-03-06 |
Xenoport, Inc. |
Prodrugs of GABA analogs, compositions and uses thereof
|
|
JP2005518411A
(ja)
*
|
2002-01-16 |
2005-06-23 |
エンド ファーマシューティカルズ インコーポレーテッド |
中枢神経系の障害を治療する製薬組成物及び方法
|
|
AU2002316231A1
(en)
*
|
2002-02-19 |
2003-09-29 |
Xenoport, Inc. |
Methods for synthesis of prodrugs from 1-acyl-alkyl derivatives and compositions thereof
|
|
AU2003222033A1
(en)
|
2002-03-20 |
2003-10-08 |
Xenoport |
Cyclic 1-(acyloxy)-alkyl prodrugs of gaba analogs, compositions and uses thereof
|
|
EP1549323A2
(en)
*
|
2002-05-07 |
2005-07-06 |
A & D Bioscience, Inc. |
Conjugates comprising central nervous system active drug
|
|
AU2003243180A1
(en)
*
|
2002-05-17 |
2003-12-12 |
Xenoport, Inc. |
Amino acid conjugates providing for sustained systemic concentrations of gaba analogues
|
|
US7060727B2
(en)
*
|
2002-12-11 |
2006-06-13 |
Xenoport, Inc. |
Prodrugs of fused GABA analogs, pharmaceutical compositions and uses thereof
|
|
US20040162351A1
(en)
*
|
2002-12-11 |
2004-08-19 |
Gallop Mark A. |
Orally administered dosage forms of fused GABA analog prodrugs having reduced toxicity
|
|
NZ539972A
(en)
|
2002-12-13 |
2008-05-30 |
Warner Lambert Co |
Alpha-2-delta ligand to treat lower urinary tract symptoms
|
|
CA2451267A1
(en)
|
2002-12-13 |
2004-06-13 |
Warner-Lambert Company Llc |
Pharmaceutical uses for alpha2delta ligands
|
|
GB0301143D0
(en)
*
|
2003-01-17 |
2003-02-19 |
Amedis Pharm Ltd |
Compounds and their use
|
|
JP2006522146A
(ja)
*
|
2003-03-31 |
2006-09-28 |
ゼノポート，インコーポレイティド |
Ｇａｂａ類似体のプロドラッグを使用するのぼせの治療または予防
|
|
CA2537837A1
(en)
*
|
2003-09-11 |
2005-03-24 |
Xenoport, Inc. |
Treating and/or preventing urinary incontinence using prodrugs of gaba analogs
|
|
EP2156863A3
(en)
|
2003-09-12 |
2011-01-12 |
Pfizer Limited |
Combinations comprising alpha-2-delta ligands and serotonin / noradrenaline reuptake inhibitors
|
|
CA2538802C
(en)
*
|
2003-09-17 |
2015-01-27 |
Xenoport, Inc. |
Treating or preventing restless legs syndrome using prodrugs of gaba analogs
|
|
PT1677767E
(pt)
*
|
2003-10-14 |
2011-10-13 |
Xenoport Inc |
Forma cristalina de análogo de ácido gama-aminobutírico
|
|
JP5646126B2
(ja)
|
2003-12-11 |
2014-12-24 |
サノビオン ファーマシューティカルズ インクＳｕｎｏｖｉｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃ． |
鎮静剤と神経伝達物質調節剤の併用、および睡眠の質の向上方法および鬱の治療方法
|
|
US20050209332A1
(en)
*
|
2004-03-17 |
2005-09-22 |
Hikal Limited |
Gabapentin analogues and process thereof
|
|
EP1763503A1
(en)
|
2004-03-17 |
2007-03-21 |
Hikal Limited |
4-t-butylgabapentin and its synthesis
|
|
US7632864B2
(en)
*
|
2004-03-17 |
2009-12-15 |
Hikal Ltd. |
Gabapentin analogues and process thereof
|
|
WO2006050514A1
(en)
|
2004-11-04 |
2006-05-11 |
Xenoport, Inc. |
Gabapentin prodrug sustained release oral dosage forms
|
|
CA2672044A1
(en)
*
|
2006-12-08 |
2008-06-19 |
Xenoport, Inc. |
Use of prodrugs of gaba analogs for treating diseases
|
|
PL2125021T3
(pl)
|
2006-12-22 |
2011-10-31 |
Recordati Ireland Ltd |
Leczenie skojarzone zaburzeń w obrębie dolnych dróg moczowych z zastosowaniem ligandów α2δ i przeciwzapalnych leków niesterydowych (NSAIDs)
|
|
WO2008103319A2
(en)
|
2007-02-16 |
2008-08-28 |
Ark Diagnostics, Inc. |
Compounds and methods for use in detecting gabapentin
|
|
US20090041806A1
(en)
*
|
2007-06-15 |
2009-02-12 |
Xenoport, Inc. |
Use of prodrugs of gaba analogs, antispasticity agents, and prodrugs of gaba b receptor agonists for treating spasticity
|
|
US20090118365A1
(en)
*
|
2007-11-06 |
2009-05-07 |
Xenoport, Inc |
Use of Prodrugs of GABA B Agonists for Treating Neuropathic and Musculoskeletal Pain
|
|
US7872046B2
(en)
|
2008-01-25 |
2011-01-18 |
Xenoport, Inc. |
Crystalline form of a (3S)-aminomethyl-5-methyl-hexanoic acid prodrug and methods of use
|
|
WO2009094577A2
(en)
|
2008-01-25 |
2009-07-30 |
Xenoport, Inc. |
Mesophasic forms of (3s)-aminomethyl-5-methyl-hexanoic acid prodrugs and methods of use
|
|
EP2250143B1
(en)
*
|
2008-01-25 |
2016-04-20 |
XenoPort, Inc. |
Method for the enzymatic kinetic resolution of acyloxyalkyl thiocarbonates used for the synthesis of acyloxyalkyl carbamates
|
|
EP3075722A1
(en)
|
2008-10-08 |
2016-10-05 |
Xgene Pharmaceutical Inc |
Gaba conjugates and methods of use thereof
|
|
WO2010048423A1
(en)
|
2008-10-24 |
2010-04-29 |
Ark Diagnostics, Inc. |
Levetiracetam immunoassays
|
|
WO2010099200A1
(en)
*
|
2009-02-24 |
2010-09-02 |
Nektar Therapeutics |
Oligomer-amino acid conjugates
|
|
US20110124705A1
(en)
*
|
2009-11-24 |
2011-05-26 |
Xenoport, Inc. |
Prodrugs of alpha-2-delta ligands, pharmaceutical compositions and uses thereof
|
|
US20110130454A1
(en)
*
|
2009-11-24 |
2011-06-02 |
Xenoport, Inc. |
Prodrugs of gamma-amino acid, alpha-2-delta ligands, pharmaceutical compositions and uses thereof
|
|
US9066853B2
(en)
|
2013-01-15 |
2015-06-30 |
Warsaw Orthopedic, Inc. |
Clonidine compounds in a biodegradable fiber
|
|
US9970929B2
(en)
|
2013-01-18 |
2018-05-15 |
Ark Diagnostics, Inc. |
Voriconazole immunoassays
|
|
HUE047629T2
(hu)
|
2013-01-28 |
2020-05-28 |
Lopez Hector L |
Eljárások ß-alanin tolerancia, farmakodinamika és hatékonyság javítására és azok alkalmazása
|
|
ES2674704T3
(es)
|
2013-02-13 |
2018-07-03 |
Ark Diagnostics, Inc. |
Inmunoensayos de posaconazol
|
|
US20210221768A1
(en)
|
2018-05-14 |
2021-07-22 |
Xgene Pharmaceutical Inc. |
Crystalline forms of 1-(acyloxy)-alkyl carbamate drug conjugates of naproxen and pregabalin
|